AKAP1 and Alzheimer disease: Ligustilide‐mediated interactions of protein kinase A (PKA) and AKAP1 ameliorate the imbalance between mitochondrial fission and fusion in the brains of AD mouse model, alleviate oxidative stress injury and inhibit apoptosis.